Bopindolol
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | C07AA17 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
69010-88-4 |
| PubChem (CID) | 44112 |
| DrugBank |
DB08807 |
| ChemSpider |
40146 |
| UNII |
KT304VZO57 |
| KEGG |
D07537 |
| ChEMBL |
CHEMBL357995 |
| Chemical and physical data | |
| Formula | C23H28N2O3 |
| Molar mass | 380.48 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for its active metabolite 4-(3-t-butylamino-2-hydroxypropoxy)-2-methylindole.[1]
References
- ↑ Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.
This article is issued from Wikipedia - version of the 6/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
